KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹13 Cr | ₹8.81 Cr | ₹-0.72 Cr | ₹7.03 Cr | ₹1.61 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹8.81 Cr |
| Mar2023 | ₹-0.72 Cr |
| Mar2022 | ₹7.03 Cr |
| Mar2021 | ₹1.61 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 50.37 | |
| Mar2024 | ₹8.81 Cr | Positive | |
| Mar2023 | ₹-0.72 Cr | Negative | |
| Mar2022 | ₹7.03 Cr | 335.44 | |
| Mar2021 | ₹1.61 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹644.5 Cr | 18.4% | 36.5% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 18.4% |
36.5% |
-15.3% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses